| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 4,487,000 | 4,029,000 | 4,179,000 | 3,928,000 | | Cost of Revenue | 3,492,000 | 3,146,000 | 3,194,000 | 2,956,000 | | | Gross Profit | 995,000 | 883,000 | 985,000 | 972,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 71,000 | 72,000 | 79,000 | 63,000 | | Non Recurring | (25,000) | (36,000) | (1,000) | (1,000) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 949,000 | 847,000 | 907,000 | 910,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,000 | 19,000 | 22,000 | 25,000 | | Earnings Before Interest And Taxes | 956,000 | 866,000 | 929,000 | 935,000 | | Interest Expense | 39,000 | 38,000 | 36,000 | 39,000 | | Income Before Tax | 917,000 | 828,000 | 893,000 | 896,000 | | Income Tax Expense | 288,000 | 238,000 | 212,000 | 152,000 | | Minority Interest | (6,000) | (7,000) | (7,000) | (18,000) | | | | Net Income From Continuing Ops | 623,000 | 583,000 | 674,000 | 726,000 | | | Non-recurring Events | | Discontinued Operations | (116,000) | 1,000 | 16,000 | 1,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 507,000 | 584,000 | 690,000 | 727,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $507,000 | $584,000 | $690,000 | $727,000 |
|
1.47% Nasdaq 
Income Statement
